OncoC4

Rockville, MD · Founded 2020 · Privately Held (backing)

Operator of a biopharmaceutical company intended for the discovery of novel biologicals for cancer and neurodegenerative disease treatments. OncoC4 is based in Rockville, MD and was founded in 2020. Its last reported valuation was $660 million in Sep 2025. It has raised $50 million.

Last reported valuation
$660.0M
Oct 2026
Priced at
—
Total raised
$50.0M
Last round
—

Who backs OncoC4?

4 investors
InvestorType
National Institutes of HealthOther
3E Bioventures CapitalVenture capital
Greater Bay Area HomelandOther
Kaitai Capital—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

OncoC4 investors

4 investors are on record for OncoC4, including National Institutes of Health, 3E Bioventures Capital, Greater Bay Area Homeland and Kaitai Capital.

Free account
More of OncoC4 with a free account
  • ·Watch OncoC4: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 4 firms already write checks for companies like OncoC4. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View